ENTRUST Resource Solutions (ERS), specialist in Life Sciences and Healthcare talent acquisition, continues to see the results of an ambitious development plan as it reports a turnover increase of 30% to £5.5million.
Relating to financial year end March 2022, the same period also saw a 50% growth in headcount across the group including the creation of three new strategic roles: Group Operations Director, and two Divisional Directors.
These results are, in part, attributable to ERS’ ongoing response to the COVID-19 pandemic during 2021, which saw sector demand for its specialist resourcing services continue to increase. However, they are also indicative of a pre-pandemic predicted growth within the UK Life Sciences sector.
The company, which operates from three strategic locations across the UK, specialises in what it terms “bench to board” resourcing activity, recruiting for contract and permanent roles at all levels within the life science, healthcare, pharmaceutical and biotechnology sectors.
During 2021 the company was responsible for placing 650 personnel across the UK, with a primary focus upon the fields of technology development and manufacture, quality assurance and scientific and laboratory activity.
Chief Executive Officer, Ryan Watson, comments: “ERS continues to meet the twin challenges of a UK talent shortage and demand at all levels, not least through a commitment to diversity and cross-sector talent acquisition.
“The UK Life Sciences sector is incredibly buoyant and is forecast to remain so for the foreseeable future. A recent report by the UK Government’s Office for Life Sciences highlights seven core disease and technology areas where there is an opportunity for Government, industry, the NHS, medical research charities and academia to work together to improve treatment options and patient outcomes.
“The foundation of this opportunity lies in the provision of relevant talent, for which ERS has earned an outstanding reputation, based upon our objective to support both client and candidate at an unprecedented level.”
As the company embarks upon the new financial year, it continues to implement a robust growth strategy including the development of a training academy in collaboration with Purdue University, Indiana and closer to home, the creation of a base in Warrington, designed to accommodate a growing team whilst consolidating its existing connection with the thriving Pharmaceutical and Life Science industry across the North West and Wales.